Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Review Status	Status Date	View
JXSB2000017	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2020-09-19	Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;Bristol-Myers Squibb Company	In Review	2020-09-18	view
JXSB2100006	纳武利尤单抗注射液	nivolumab	Injection	Biological Products(2.2)	Supplementary Application	2021-01-08	Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;Bristol-Myers Squibb Company	In Review	2021-01-07	view
JXSB2101075	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2021-10-22	Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;Bristol-Myers Squibb Company			view
JXSB2101088	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2021-11-12	Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;Bristol-Myers Squibb Company			view
JXSB2101113	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2021-12-27	Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;Bristol-Myers Squibb Company			view
JXSB2300139	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2023-11-30	Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;Bristol-Myers Squibb Company			view
JXSL1900033	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Import Drug Application	2019-03-27	Bristol-Myers Squibb Pharma Eeig	In Review	2019-03-26	view
JXSL1900034	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Import Drug Application	2019-03-27	Bristol-Myers Squibb Pharma Eeig	In Review	2019-03-26	view
JXSL1900069	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Import Drug Application	2019-08-24	Bristol-Myers Squibb Company	In Review	2019-08-23	view
JXSL1900085	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Import Drug Application	2019-09-16	Bristol-Myers Squibb Company	In Review	2019-09-13	view
JXSL1900095	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Import Drug Application	2019-09-28	Bristol-Myers Squibb Company	In Review	2019-09-27	view
JXSL1900097	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Import Drug Application	2019-09-28	Bristol-Myers Squibb Company	In Review	2019-09-27	view
JXSL1900150	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Import Drug Application	2019-12-21	Bristol-Myers Squibb Company	In Review	2019-12-20	view
JXSL1900154	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Import Drug Application	2020-01-01	Bristol-Myers Squibb Company	In Review	2019-12-31	view
JXSL2000010	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Import Drug Application	2020-01-21	Bristol-Myers Squibb Company	In Review	2020-01-20	view
JXSL2000061	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Import Drug Application	2020-05-30	Bristol-Myers Squibb Company	In Review	2020-05-29	view
JXSL2000102	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Import Drug Application	2020-07-04	Bristol-Myers Squibb Company	In Review	2020-07-03	view
JXSL2000110	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Import Drug Application	2020-07-04	Bristol-Myers Squibb Company	In Review	2020-07-03	view
JXSL2000151	纳武利尤单抗注射液	nivolumab	Injection	Biological Products(2.2)	Import Drug Application	2020-09-14	Bristol-Myers Squibb Company	In Review	2020-09-11	view
JXSL2101047	纳武利尤单抗注射液	nivolumab	Injection	Biological Products(2.2)	Import Drug Application	2021-06-29	Bristol-Myers Squibb Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd			view